One of the driving forces in today’s marketplace is intellectual property. Ideas and designs are now as important to corporate success as financial and operational expertise. At Foley Hoag, we understand the value of protecting our clients’ intellectual property; and we have the experience to provide a global perspective. learn more

News more

  • Foley Hoag Selected as one of 2008 Top 100 Law Firms for Diversity  [Read More]
  • Foley Hoag Names Three New Partners  [Read More]

Publications more

  • Prescription Drug Pedigree: Proliferation of State Laws Calls for Federal Action [Read More]
  • The Benefits of Patent Marking – And of Getting It Right [Read More]
  • Health Canada Releases Draft Biosimilar Approval Guidance [Read More]
  • Bipartisan Follow-on-Biologics Legislation Introduced in the House [Read More]
  • Supreme Court Favors Express Preemption of Medical Device State Tort Claims  [Read More]

Events more

May 15, 2008 Skidmore Business Network presents Richard Laxer, '83 ~ President and CEO, GE Capital Solutions [Read More] Emerging Enterprise Center at Foley Hoag
Waltham, MA
May 20, 2008 Deciphering the Funding Value-Chain: How Seed Capital Scroungers Become Bankers' Best Friends [Read More] Emerging Enterprise Center at Foley Hoag
Waltham, MA
May 21, 2008 Shining the Light on You: Catching the Interest and Capturing Investment Dollars in Today's Turbulent Markets for Small and Microcap Companies [Read More] Emerging Enterprise Center at Foley Hoag
Waltham, MA
May 29, 2008 FDA Boot Camp: Basic Training for Products Liability and Patent Lawyers [Read More] Hotel Whitcomb
San Francisco, CA
June 4, 2008 What's New in Selected Fields - Neuroscience and Neurotechnology [Read More] Emerging Enterprise Center at Foley Hoag
Waltham, MA

Client Successes more

  • HyperBranch Medical Technology, Inc.
    For our client HyperBranch Medical Technology, Inc., a leader in the field of polymeric medical sealants, we assisted with the intellectual property portfolio strategy in connection with obtaining CE Mark designation for the company’s OcuSeal product. OcuSeal is a liquid ocular bandage used to stabilize ocular wounds following surgical or non-surgical trauma. CE Marking denotes that a product complies with all requirements of European health, safety, and environmental product legislation, and is an important step in bringing products to market overseas. HyperBranch began its research in 2004 with the objective to develop strong enough polymer sealants to ultimately replace sutures that would be easy to use, and would not interfere with natural healing. The Durham, North Carolina medical device company has also, been developing advanced surgical sealants for dura (brain), pleural (lung) and hernia mesh fixation. These products are all at various stages of clinical and pre-clinical development. Read more about HyperBranch Medical Technology here. [Read More]
  • Advising a Leading Proteomics and Drug Discovery Company
    We represented a proteomics and drug discovery company in connection with a research, development and commercialization collaboration with a company possessing human antibody technology, including the development and commercialization of human antibodies directed against more than 100 different protein targets. Our service to this client has included devising a number of business and legal mechanisms for prioritizing the different protein targets, maintaining commercialization rights in certain fields, and protecting against claims of intellectual property infringement. [Read More]